In my experience, India delivers the most value as part of a global development plan, not as a cost line. The sponsors who succeed treat the country as part of global development and hold their partners to global standards
We are moving from a model based mainly on observation towards one supported by imaging, measurements, biomarkers, artificial intelligence and increasingly sophisticated formulation
We are expanding into the Middle East, Southeast Asia and Africa, where high musculoskeletal disease burden, growing private healthcare and demand for affordable quality care create strong opportunities for Indian-developed solutions
Yash Medicare is a WHO-GMP certified contract manufacturer and exporter based in Gujarat, India, specializing in dermatological external preparations like pharmaceutical creams, gels, lotions, and ointments
Continuing with its expansion, S Kant Healthcare is setting up a plant in Uganda which will be operational in the next few months
The global pharma industry is becoming more patient centric with a lot of patient support schemes. There is a strong realization that pharma has a duty of care towards health prevention as well rather than just treatment
Samrudh Pharmacare has identified a highly lucrative and socially impactful growth vector by focusing on suppositories and ointments. While suppositories are heavily utilized globally, they remain an under-penetrated, "new concept" in the domestic Indian retail sector
Amino acid analysis verifies sequence integrity, batch consistency, and purity for modern peptide therapeutics and GLP-1 receptor agonists. This technology uses ion-exchange chromatography with post-column derivatization to deliver high-resolution, pharmacopeia-compliant profiling for R&D and quality control
We are also building customer experience facility in Thane
While conventional testing is more of a report card on your current health status, testing for microbiomes can provide an insight into the biological context in which illness arises
BPL's next phase of growth is anchored in expanding its portfolio beyond medical equipment to offer integrated digital healthcare solutions
Over the years, the medical imaging and diagnostics sector has transitioned primarily from the use of standalone diagnostic equipment to the use of integrated data-driven ecosystems
India's clinical research industry is evolving beyond project-based trials to deliver continuous evidence across a molecule's entire lifecycle
By reducing pain, needle anxiety and related risks, needle-free injection systems are improving treatment experiences, supporting better adherence, and emerging as a scalable solution
We are trying to find the applications for the cognitive technologies developed at IISc for wider populations and are also seeking CSR support to implement them
The Centre for Cellular and Molecular Platforms (C-CAMP) has dedicated biopharma development programs to work with young developers as well as corporates on their research and medical needs
Biocon is actively advancing in the peptide field, having already secured regulatory approvals for certain critical molecules, with a clear focus on GLP-1 analogs and other peptides
We are strengthening our market expansion through investment in manpower, regional reach and faster service turnaround to enhance application-led customer support across key industries
Country’s deep scientific talent pool and its growing role as a clinical trial destination makes it central to how Parexel serves sponsors
_256_384.jpeg)
One of our major priorities in next 3-5 years is the introduction of a kit-based version of CanAssist Breast, enabling hospitals conduct the test locally
Since 2022, we have grown threefold and our growth story is built on scale, scientific innovation and deep customer partnerships
The fast growing pharma industry in India offers us a wide range of opportunities and we represent the world's leading technology providers in india
We offer fully automated chromatography systems with customized softwares, providing customers ample time to manage R&D while the samples are being processed and results decoded
We are building the bridge between complex molecular data and everyday clinical decisions
Subscribe To Our Newsletter & Stay Updated
